Testing effectiveness (Phase 2)WithdrawnNCT05572476
What this trial is testing
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer
Who this might be right for
Small Cell Lung CancerPlatinum-Sensitive Lung Small Cell CarcinomaExtensive-stage Small-cell Lung Cancer
Institut Bergonié